Additionally, evidence has demonstrated that fasting can enhance insulin sensitivity, suppress endogenous glucose production in diabetes, promote weight loss, and refine body composition, reinforcing its potential as a therapeutic modality for managing type 1 and type 2 diabetes mellitus, it and can be judiciously implemented with professional oversight when deemed appropriate (Herz et al. 2023). The gene discussed is INS; the disease is diabetes mellitus.